REG - Natwest Markets PLC - Publication of Supplementary Prospectus

RNS Number : 0321T Natwest Markets PLC 13 February 2026 NatWest Markets PlcPublication of Supplementary ProspectusThe following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:Supplementary Prospectus dated 13 February 2026 to the NatWest Markets Plc £25,000,000,000 Euro Medium Term Note Programme of 5 December 2025 (the "Supplementary Prospectus").To view the full document, please paste the following URL into the address bar of your browser:http://www.rns-pdf.londonstockexchange.com/rns/0321T_1-2026-2-13.pdfA copy of the above Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at:https://data.fca.org.uk/#/nsm/nationalstoragemechanism For further information, please contact:Mark AnwenderNatWest Treasury DCM, Head of Documentation and FundingTel: +44 (0) 207 085 5143DISCLAIMER - INTENDED ADDRESSEESPlease note that the information contained in the Supplementary Prospectus (and the Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside of these countries and/or to whom the offer contained in the Prospectus and the Supplementary Prospectus is not addressed. Prior to relying on the information contained in the Prospectus and the Supplementary Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.Your right to access this service is conditional upon complying with the above requirement.Legal Entity Identifier:NatWest Markets Plc - RR3QWICWWIPCS8A4S074This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END PSPGPUAGPUPQGRW